drugset / Trial / NCT02665377
Prevention of Akute Kidney Injury, Hearttransplant, ANP
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Prospective, blinded, placebo-controlled trial. Patients: Adult patients (\>18 years of age) undergoing de novo Htx, with a preoperative GFR \> 30ml/min, not receiving an ABO-incompatible organ with an ischemia time of \> 6 hours. A donor age \> 70 years is an exclusion criteria. Intervention: Infusion of h-ANP fore five days, starting at the induction of anesthesia. Outcome: Kidney function, evaluated with serum creatinine day 1-7 and kidney clearance, 4-5 Days after Htx plus after 3 and 12 months.
Timeline
- Start
- 2016-09-25
- Primary completion
- 2022-01-08
- Completion
- 2022-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ANP | Peptide | 50 unknown | — |